3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
4
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Myeloproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Glioma
1
Glioblastoma
1
Fibrosarcoma
1
Interventions
Cyclophosphamide
3
sodium-iodide symporter
1
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
cemiplimab
1
X-Rays
1
Whole-Body Irradiation
1
Vorinostat
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Particle Accelerators
1
Nivolumab
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Etoposide
1
Disulfides
1
Cyclosporine
1
CTLA-4 Antigen
1
Busulfan
1
Biopsy
1
A-dmDT390-bisFv(UCHT1) protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
selinexor
×
30 days
×
Clear all
No trials found.